FDA Panel Greenlights RSV Vaccine for Elderly

With some concerns and caveats that put a strong emphasis on post-marketing surveillance, vaccine advisors for the Food and Drug Administration have greenlit two vaccines against respiratory syncytial virus infections in people aged 60 years and older.